Martin Shkreli, also known as “Pharma Bro,” recently discussed his short positions on Bitcoin, MicroStrategy, and several quantum computing stocks. He argues that these assets are overvalued and a correction is imminent. Despite his controversial past, Shkreli’s track record suggests an understanding of market dynamics.
However, investors should approach his predictions with caution given the volatile nature of these assets.
Source
